Case File
efta-01451594DOJ Data Set 10OtherEFTA01451594
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01451594
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
SOF III - 1081 Southern Financial LLC
Section 7: Simmer), of Terms and Conditions
Secondary Opportunities Fund III. LP
Successor Funds
Without the consent of 66%% in interest of the Limited Partners, none of the General Partner,
the Second GP, the Manager or any entity that is under the control of DB PE will close
another multiple third party investor fund having a substantially similar investment objective
and strategy as the Fund until the earlier of.
(i) the date when 75% of aggregate Commitments have been invested, committed or
reserved for investment or allocated or reserved to meet the obligations of the Fund;
(ii) the end of the Investment Period; or
(iii) the termination of the Fund.
Notwithstanding the foregoing, the Manager or any other entity that is under the control or
management of DB PE may, at any time, close other multiple third party investor funds with
investment objectives and strategies that overlap with the Fund but are dedicated to pursuing
investment opportunities relating to specific asset categories or strategies, including, without
limitation, Real Estate Secondary Opportunities Fund, LP (including its feeder funds, "RE
SOF") (each, a 'Complementary Fund").
Allocation of
Subject to the *Successor Funds' restrictions described above, DB PE may sponsor or advise
Investment
various investment vehicles, including Complementary Funds and separate accounts
Opportunities
(together with the Fund, the "Investment Platforms"), some of which may have overlapping
investment strategies and investment committee members with those of the Fund (see
Section 9: Conflicts of Interest of this Memorandum).
DB PE will allocate investment
opportunities among the Investment Platforms on an equitable basis in its good faith
discretion and in accordance with its internal investment allocation guidelines. These are
based on the applicable investment guidelines of such Investment Platforms, portfolio
diversification requirements, regulatory requirements and other appropriate factors.
Transfers and
Limited Partners generally may not sell, assign, transfer or pledge their Interests except as
Withdrawals
permitted by the Fund Partnership Agreement which will require, inter the, the prior written
consent of the Manager. Limited Partners generally may not withdraw from the Fund.
Reporting, Valuations
Limited Partners will receive audited annual accounts (also comprising a Managers report
and Annual Meeting
and such disclosures as are required by the AIFMD) prepared in accordance with US GAAP
or International Financial Reporting Standards as well as unaudited quarterly financial
statements (in respect of the second and third quarters of each Fiscal Year only) and
unaudited quarterly capital accounts.
Limited Partners will also receive such periodic
disclosures as are required in accordance with the AIFMD (including changes to leverage.
liquidity and risk management provisions).
Disclosure of changes
to the leverage
provisions
The Fund will hold annual meetings to provide Umited Partners with the opportunity to review
and discuss with the Manager and its employees the Fund's investment activities and
portfolio.
Limited Partners will receive unaudited quarterly financial reports regarding the Fund which
will include the amount of leverage that has been utilised by the Fund.
Any amendments to the leverage provisions of the Fund will require an amendment to the
Fund Partnership Agreement. See 'Amendments to Fund Partnership Agreement' below for
further details.
Co-Investment
The Manager may offer co-investment opportunities to any Limited Partner in its sole
discretion.
Confidential Private Placement Memorandum
59
CONFIDENTIAL — PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0108288
CONFIDENTIAL
SDNY_GM_00254472
EFTA01451594
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.